Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Diffuse Parenchymal Lung Disease
•
LAM
What is your approach to counseling and managing patients with LAM desiring pregnancy?
Related Questions
What is your approach to treatment in a patient with radiographic UIP but pathologic evidence of both fibrotic NSIP and UIP?
How long after initiating mycophenolate do you wait before tapering prednisone off in patients with myositis-associated ILD?
Do you utilize cytokine panels to guide treatment of patients with EGPA?
Are there benefits to adding IL5/IL5 receptor blockade in patients with vasculitic manifestations of EGPA?
How do you approach pre-operative risk assessment and optimization in a patient with interstitial lung disease?
How do you manage pleuroparenchymal fibroelastosis in a patient with seronegative RA that is progressing on Rituxan and DMARD therapy?
Do more fractionated regimens reduce severe toxicity over SBRT in patients with ILD and early-stage NSCLC?
Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?
What is the duration of steroids that you prescribe for organizing pneumonia?
When do you consider systemic therapy for patients with progressive fibrosing mediastinitis?
